Table 1

Demographic and disease characteristics of patients receiving the same treatment at vaccination and at 1

RA (n = 163)

SpA (n = 139)


Treatment group

MTX monotherapy

Anti-TNF monotherapy

Anti-TNF + MTX

Anti-TNF monotherapy

Anti-TNF + MTX

NSAID/analgesics


Number of patients at vaccination

85

79

89

83

83

86


Number (%) of patients remaining on original therapy at 1.5-year follow-up

57 (67%)

50 (63%)

56 (63%)

47 (47%)

49 (59%)

43 (50%)


Age, mean (SD); years

63.5 (11)

59.9 (14)

60.5 (9)

50.3 (12)

51.6 (11)

52.8 (12)


Female (%)

77%

90%

75%

38%

57%

49%


Disease duration, mean (SD); years

12.6 (10)

19.8 (11)

16.8 (11)

16.8 (11)

13.1 (10)

13.6 (12)


RF positive (%)

81

86

84

-

-

-


Anti-CCP positive (%)

77

76

88

-

-

-


HLA B27 positive (%)

-

-

-

53

33

63


Crnkic Kapetanovic et al. Arthritis Research & Therapy 2013 15:R1   doi:10.1186/ar4127

Open Data